Translational Cancer imaging in preclinical animal models
What can the Vevo Imaging systems do for Oncology?
The Vevo Imaging systems is the leader in cutting edge in vivo imaging solution with high frequency ultrasound and photoacoustic imaging. Cancer researchers are empowered with unique solutions to meet the translational priorities in research towards precision medicine. The Vevo research community has witnessed over 300 cancer publications and latest breakthroughs in targeted therapeutics.
Cancer is a complex disease, and cancer research needs an advanced imaging solution. Today’s cancer researcher can visualize cancer in all its dimensions and in models that are relevant to human cancer. Deep tissue non-invasive imaging of cancers in soft tissues uniquely positions the Vevo for Oncology. Combine that with imaging the microenvironment for changes in angiogenesis, hypoxia and molecular markers, drug delivery, to name a few, make the Vevo Imaging systems the first choice for Oncology research, in the age of precision medicine.
Screen and quantify tumor in all its dimensions – Learn more about VevoLAZR to get 5 data sets from one scan.
+ High resolution assessment of primary and metastatic burden in soft tissues
+ Rapid assessment on quality of predictive models and experimental therapeutics in minutes
- Image guided development of relevant models of cancer progression
- Image guided assessment of chemotherapy in real time
- Image guided delivery of radiation therapy in real time to optimize therapeutic window
+ Multimodal investigation on microenvironment with a histology guided approach
+ Non Invasive investigation of translational molecular biomarkers in situ